{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:32:59Z","timestamp":1791923579865,"version":"4.3.4"},"reference-count":181,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Recent research establishes carbohydrate response element-binding protein (ChREBP) as a central regulator of fructose-induced hepatic lipogenesis, underscoring its critical role in mediating the effects of excessive sugar intake on liver metabolism. Consequently, this narrative review presents a perspective of hepatic sugar metabolism and ChREBP signaling, highlighting areas for further exploration to better understand and address the metabolic consequences of fructose-driven activation of ChREBP. The discussion encompasses five principal domains: (1) fructose metabolism; (2) the structure and function of ChREBP; (3) interactions between glucose and fructose metabolism with ChREBP activity; (4) mechanisms that intensify fructose\u2019s influence on ChREBP pathways; and (5) future research opportunities. Under physiological conditions, ChREBP mitigates accumulation of glycolytic intermediates; however, excessive sugar consumption overwhelms these capacities, thereby increasing lipogenesis. Fructose demonstrates notably stronger activation of ChREBP in vivo relative to glucose. Given ChREBP\u2019s dual role in maintaining metabolic homeostasis and promoting insulin resistance under high fructose intake, therapeutic targeting poses considerable challenges. We propose the testable hypothesis that the MG generated from excessive fructose metabolism may bind to ChREBP\u2019s lysine residues, stabilizing the protein and reducing degradation by impeding ubiquitination. This stabilization of ChREBP would prolong its activity, thereby further promoting sustained hepatic lipogenesis and exacerbating the risk of MASLD. Experimental and clinical research is needed to confirm its validity and define the molecular pathways involved. Future studies should aim to identify glucose metabolites involved in ChREBP regulation and clarify its beneficial versus adverse effects. The specific functions and regulation of ChREBP\u03b2 vs. ChREBP\u03b1 remain to be elucidated.<\/jats:p>","DOI":"10.3390\/life16081313","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:09:36Z","timestamp":1786435776000},"page":"1313","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sugar Shockwaves: How the Fructose\u2013Glucose\u2013ChREBP Pathway Hijacks Liver Metabolism"],"prefix":"10.3390","volume":"16","author":[{"given":"Alejandro","family":"Gugliucci","sequence":"first","affiliation":[{"name":"Department of Research, Touro University California, Vallejo, CA 94592, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Lin, X., and Li, H. (2021). Obesity: Epidemiology, Pathophysiology, and Therapeutics. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.706978"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee for Diabetes (2026). Obesity and Weight Management for the Prevention and Treatment of Diabetes: Standards of Care in Diabetes-2026. Diabetes Care, 49, S166\u2013S182.","DOI":"10.2337\/dc26-S008"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1177\/193229681000400432","article-title":"Fructose: Pure, white, and deadly? Fructose, by any other name, is a health hazard","volume":"4","author":"Bray","year":"2010","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s11883-012-0276-6","article-title":"Fructose and risk of cardiometabolic disease","volume":"14","author":"Bray","year":"2012","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3945\/an.112.002816","article-title":"Energy and fructose from beverages sweetened with sugar or high-fructose corn syrup pose a health risk for some people","volume":"4","author":"Bray","year":"2013","journal-title":"Adv. Nutr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1038\/ijo.2008.248","article-title":"Fructose: Should we worry?","volume":"32","author":"Bray","year":"2008","journal-title":"Int. J. Obes."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/ajcn\/86.4.895","article-title":"How bad is fructose?","volume":"86","author":"Bray","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e013543","DOI":"10.1136\/bmjopen-2016-013543","article-title":"Health and economic benefits of reducing sugar intake in the USA, including effects via non-alcoholic fatty liver disease: A microsimulation model","volume":"7","author":"Vreman","year":"2017","journal-title":"BMJ Open"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrgastro.2010.41","article-title":"The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome","volume":"7","author":"Lim","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1542\/peds.2011-2912","article-title":"Toward a unifying hypothesis of metabolic syndrome","volume":"129","author":"Bremer","year":"2012","journal-title":"Pediatrics"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1161\/01.ATV.0000186208.06964.91","article-title":"Fast food, central nervous system insulin resistance, and obesity","volume":"25","author":"Isganaitis","year":"2005","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.jada.2010.06.008","article-title":"Fructose: Metabolic, hedonic, and societal parallels with ethanol","volume":"110","author":"Lustig","year":"2010","journal-title":"J. Am. Diet. Assoc."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3945\/an.112.002998","article-title":"Fructose: It\u2019s \u201calcohol without the buzz.\u201d","volume":"4","author":"Lustig","year":"2013","journal-title":"Adv. Nutr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/nutrit\/nuw046","article-title":"What is the appropriate upper limit for added sugars consumption?","volume":"75","author":"Rippe","year":"2017","journal-title":"Nutr. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00394-016-1345-3","article-title":"Controversies about sugars: Results from systematic reviews and meta-analyses on obesity, cardiometabolic disease and diabetes","volume":"55","author":"Khan","year":"2016","journal-title":"Eur. J. Nutr."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Gugliucci, A. (2023). Sugar and Dyslipidemia: A Double-Hit, Perfect Storm. J. Clin. Med., 12.","DOI":"10.3390\/jcm12175660"},{"key":"ref_18","first-page":"1","article-title":"Biomarkers of dysfunctional visceral fat","volume":"109","author":"Gugliucci","year":"2022","journal-title":"Adv. Clin. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3945\/an.116.013912","article-title":"Formation of fructose-mediated advanced glycation end products and their roles in metabolic and inflammatory diseases","volume":"8","author":"Gugliucci","year":"2017","journal-title":"Adv. Nutr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2741\/4713","article-title":"Fructose at the crossroads of the metabolic syndrome and obesity epidemics","volume":"24","author":"Mortera","year":"2019","journal-title":"Front. Biosci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/oby.21371","article-title":"Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome","volume":"24","author":"Lustig","year":"2016","journal-title":"Obesity"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.clnu.2020.12.022","article-title":"Metabolism of sugars: A window to the regulation of glucose and lipid homeostasis by splanchnic organs","volume":"40","author":"Tappy","year":"2021","journal-title":"Clin. Nutr."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.3390\/nu6072632","article-title":"Metabolic fate of fructose ingested with and without glucose in a mixed meal","volume":"6","author":"Theytaz","year":"2014","journal-title":"Nutrients"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.freeradbiomed.2023.02.013","article-title":"ChREBP-\u03b2\/TXNIP aggravates frucose-induced renal injury through triggering ferroptosis of renal tubular epithelial cells","volume":"199","author":"Guo","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00011-023-01707-1","article-title":"Fructose malabsorption in ChREBP-deficient mice disrupts the small intestine immune microenvironment and leads to diarrhea-dominant bowel habit changes","volume":"72","author":"Jang","year":"2023","journal-title":"Inflamm. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41574-023-00809-4","article-title":"The role of ChREBP in carbohydrate sensing and NAFLD development","volume":"19","author":"Carbinatti","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Ahn, B. (2023). The Function of MondoA and ChREBP Nutrient-Sensing Factors in Metabolic Disease. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24108811"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"115278","DOI":"10.1016\/j.celrep.2025.115278","article-title":"Integration of metabolomic and transcriptomic analyses reveals regulatory functions of the ChREBP transcription factor in energy metabolism","volume":"44","author":"An","year":"2025","journal-title":"Cell Rep."},{"key":"ref_29","first-page":"841","article-title":"Can the hyperactivity of lipogenesis cause hepatic steatosis? A role for ChREBP","volume":"24","author":"Robichon","year":"2008","journal-title":"Med. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"100623","DOI":"10.1016\/j.jbc.2021.100623","article-title":"Adaptive and maladaptive roles for ChREBP in the liver and pancreatic islets","volume":"296","author":"Katz","year":"2021","journal-title":"J. Biol. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"429","DOI":"10.5483\/BMBRep.2018.51.9.197","article-title":"Recent insights into the role of ChREBP in intestinal fructose absorption and metabolism","volume":"51","author":"Lee","year":"2018","journal-title":"BMB Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1172\/JCI95008","article-title":"ChREBP refines the hepatic response to fructose to protect the liver from injury","volume":"127","author":"Hall","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"154222","DOI":"10.1016\/j.metabol.2020.154222","article-title":"DDB1 E3 ligase controls dietary fructose-induced ChREBP\u03b1 stabilization and liver steatosis via CRY1","volume":"107","author":"Tong","year":"2020","journal-title":"Metabolism"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1042\/BJ20111280","article-title":"Fructose 2, 6-bisphosphate is essential for glucose-regulated gene transcription of glucose-6-phosphatase and other ChREBP target genes in hepatocytes","volume":"443","author":"Arden","year":"2012","journal-title":"Biochem. J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2101115","DOI":"10.1002\/mnfr.202101115","article-title":"ChREBP-driven DNL and PNPLA3 Expression Induced by Liquid Fructose are Essential in the Production of Fatty Liver and Hypertriglyceridemia in a High-Fat Diet-Fed Rat Model","volume":"66","author":"Bentanachs","year":"2022","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1038\/s44319-024-00121-w","article-title":"Liver ChREBP deficiency inhibits fructose-induced insulin resistance in pregnant mice and female offspring","volume":"25","author":"Li","year":"2024","journal-title":"EMBO Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3164\/jcbn.22-15","article-title":"ChREBP deficiency prevents high sucrose diet-induced obesity through reducing sucrase expression","volume":"71","author":"Sakiyama","year":"2022","journal-title":"J. Clin. Biochem. Nutr."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Carbinatti, T., R\u00e9gnier, M., Parlati, L., Benhamed, F., and Postic, C. (2023). New insights into the inter-organ crosstalk mediated by ChREBP. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1095440"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"950","DOI":"10.2337\/dc13-2085","article-title":"Dietary sugar and body weight: Have we reached a crisis in the epidemic of obesity and diabetes?: Health be damned! Pour on the sugar","volume":"37","author":"Bray","year":"2014","journal-title":"Diabetes Care"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.2047-6310.2013.00171.x","article-title":"Calorie-sweetened beverages and fructose: What have we learned 10 years later","volume":"8","author":"Bray","year":"2013","journal-title":"Pediatr. Obes."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.atherosclerosis.2016.06.048","article-title":"Short-term isocaloric fructose restriction lowers apoC-III levels and yields less atherogenic lipoprotein profiles in children with obesity and metabolic syndrome","volume":"253","author":"Gugliucci","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"A16511","DOI":"10.1161\/circ.142.suppl_3.16511","article-title":"Isocaloric Fructose Restriction Improves Postprandial Chylomicron VLDLExcursions in Adolescents with Obesity by Reducing Angiopoietin-Like Protein, 3. and Apolipoprotein, C.I.I.I","volume":"142","author":"Bains","year":"2020","journal-title":"Circulation"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1017\/S0007114521001215","article-title":"Fructose malabsorption: Causes, diagnosis and treatment","volume":"127","author":"Benardout","year":"2022","journal-title":"Br. J. Nutr."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1017\/S0007114518000417","article-title":"Excess free fructose, high-fructose corn syrup and adult asthma: The Framingham Offspring Cohort","volume":"119","author":"DeChristopher","year":"2018","journal-title":"Br. J. Nutr."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12937-020-00578-0","article-title":"Excess free fructose, apple juice, high fructose corn syrup and childhood asthma risk\u2014The National Children\u2019s Study","volume":"19","author":"Dechristopher","year":"2020","journal-title":"Nutr. J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/ejcn.2015.101","article-title":"Excess free fructose and childhood asthma","volume":"69","year":"2015","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1467-789X.2007.00389.x","article-title":"A short history of beverages and how our body treats them","volume":"9","author":"Wolf","year":"2008","journal-title":"Obes. Rev."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"31646","DOI":"10.1074\/jbc.M200544200","article-title":"Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance: Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction","volume":"277","author":"Haidari","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Olson, E., Suh, J.H., Schwarz, J.M., Noworolski, S.M., Jones, G.M., Barber, J.R., Erkin-Cakmak, A., Mulligan, K., Lustig, R.H., and Mietus-Snyder, M. (2022). Effects of Isocaloric Fructose Restriction on Ceramide Levels in Children with Obesity and Cardiometabolic Risk: Relation to Hepatic De Novo Lipogenesis and Insulin Sensitivity. Nutrients, 14.","DOI":"10.3390\/nu14071432"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"E591","DOI":"10.1152\/ajpendo.1992.262.5.E591","article-title":"Thermogenesis and fructose metabolism in humans","volume":"262","author":"Schwarz","year":"1992","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1042\/BCJ20240748","article-title":"Aldose reductase, fructose and fat production in the liver","volume":"482","author":"Delannoy","year":"2025","journal-title":"Biochem. J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1080\/10408363.2019.1711360","article-title":"Fructose and hepatic insulin resistance","volume":"57","author":"Softic","year":"2020","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s13668-023-00452-5","article-title":"Responses to Hypoxia: How Fructose Metabolism and Hypoxia-Inducible Factor-1a Pathways Converge in Health and Disease","volume":"12","author":"Kanbay","year":"2023","journal-title":"Curr. Nutr. Rep."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"20220230","DOI":"10.1098\/rstb.2022.0230","article-title":"The fructose survival hypothesis for obesity","volume":"378","author":"Johnson","year":"2023","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Lanaspa, M.A., Sanchez-Lozada, L.G., Cicerchi, C., Li, N., Roncal-Jimenez, C.A., Ishimoto, T., Le, M., Garcia, G.E., Thomas, J.B., and Rivard, C.J. (2012). Uric Acid Stimulates Fructokinase and Accelerates Fructose Metabolism in the Development of Fatty Liver. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0047948"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.evolhumbehav.2020.09.006","article-title":"Fructose and Uric Acid as Drivers of a Hyperactive Foraging Response: A Clue to Behavioral Disorders Associated with Impulsivity or Mania?","volume":"42","author":"Johnson","year":"2021","journal-title":"Evol. Hum. Behav."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.3724\/abbs.2025191","article-title":"The effect of liver-specific ketohexokinase deletion on the intestinal-liver-kidney axis in high-fructose-induced metabolic syndrome mice","volume":"58","author":"Yang","year":"2026","journal-title":"Acta. Biochim. Biophys. Sin."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e70187","DOI":"10.1111\/apha.70187","article-title":"Pax8-rtTA\/LC1-Driven Inducible Ketohexokinase Deletion Protects Against High Fructose-Induced Metabolic Syndrome in Mice","volume":"242","author":"Yi","year":"2026","journal-title":"Acta. Physiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cmet.2020.05.012","article-title":"Deletion of Fructokinase in the Liver or in the Intestine Reveals Differential Effects on Sugar-Induced Metabolic Dysfunction","volume":"32","author":"Orlicky","year":"2020","journal-title":"Cell Metab."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Elsaman, T., Mohamed, M.A., Elderdery, A.Y., Alsrhani, A., Alzahrani, B., Ghanem, H.B., Mills, J., Rayzah, M., Alzerwi, N.A.N., and Al-sultan, A. (2025). Pharmacophore-based virtual screening and in silico investigations of small molecule library for discovery of human hepatic ketohexokinase inhibitors for the treatment of fructose metabolic disorders. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1531512"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"R347","DOI":"10.1152\/ajpregu.00238.2021","article-title":"Sirtuin deficiency and the adverse effects of fructose and uric acid synthesis","volume":"322","author":"Johnson","year":"2022","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Arroyo, F.E., Monroy-S\u00e1nchez, F., Mu\u00f1oz-Jim\u00e9nez, I., Gonzaga, G., Andr\u00e9s-Hernando, A., Zazueta, C., Ju\u00e1rez-Rojas, J.G., Lanaspa, M.A., Johnson, R.J., and S\u00e1nchez-Lozada, L.G. (2019). Allopurinol prevents the lipogenic response induced by an acute oral fructose challenge in short-term fructose fed rats. Biomolecules, 9.","DOI":"10.3390\/biom9100601"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Semchyshyn, H. (2024). Fructose-mediated AGE-RAGE axis: Approaches for mild modulation. Front. Nutr., 11.","DOI":"10.3389\/fnut.2024.1500375"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/978-3-319-07320-0_14","article-title":"The axis age-rage-soluble rage and oxidative stress in chronic nkidney disease","volume":"824","author":"Gugliucci","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s10719-016-9691-1","article-title":"Targeting advanced glycation with pharmaceutical agents: Where are we now?","volume":"33","author":"Borg","year":"2016","journal-title":"Glycoconj. J."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/0306-3623(95)02054-3","article-title":"Pharmacology of methylglyoxal: Formation, modification of proteins and nucleic acids, and enzymatic detoxification\u2014A role in pathogenesis and antiproliferative chemotherapy","volume":"27","author":"Thornalley","year":"1996","journal-title":"Gen. Pharmacol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/1040-8428(94)00149-N","article-title":"Advances in glyoxalase research. Glyoxalase expression in malignancy, anti-proliferative effects of methylglyoxal, glyoxalase I inhibitor diesters and S-d-lactoylglutathione, and methylglyoxal-modified protein binding and endocytosis by the advanced glycation endproduct receptor","volume":"20","author":"Thornalley","year":"1995","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1089\/ars.2017.7424","article-title":"Glyoxalase 1 modulation in obesity and diabetes","volume":"30","author":"Rabbani","year":"2019","journal-title":"Antioxid. Redox Signal"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10719-021-09980-0","article-title":"Dicarbonyl stress, protein glycation and the unfolded protein response","volume":"38","author":"Rabbani","year":"2021","journal-title":"Glycoconj. J."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1042\/CS20160025","article-title":"Methylglyoxal-induced dicarbonyl stress in aging and disease: First steps towards glyoxalase 1-based treatments","volume":"130","author":"Rabbani","year":"2016","journal-title":"Clin. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Rabbani, N., Xue, M., Weickert, M.O., and Thornalley, P.J. (2021). Reversal of insulin resistance in overweight and obese subjects by trans-resveratrol and hesperetin combination\u2014Link to dysglycemia, blood pressure, dyslipidemia, and low-grade inflammation. Nutrients, 13.","DOI":"10.3390\/nu13072374"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"103025","DOI":"10.1016\/j.redox.2024.103025","article-title":"Increased cellular protein modification by methylglyoxal activates endoplasmic reticulum-based sensors of the unfolded protein response","volume":"69","author":"Xue","year":"2024","journal-title":"Redox Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1042\/CS20257727","article-title":"Molecular mechanisms of metabolic dysfunction-associated steatotic liver disease (MASLD): Functional analysis of glucose and fructose metabolism pathways","volume":"139","author":"Rabbani","year":"2025","journal-title":"Clin. Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ymeth.2020.06.010","article-title":"Optimized sensitive and inexpensive method to measure D-lactate as a surrogate marker of methylglyoxal fluxes in metabolically relevant contexts","volume":"203","author":"Gugliucci","year":"2022","journal-title":"Methods"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1515\/cclm-2017-0733","article-title":"Higher D-lactate levels are associated with higher prevalence of small dense low-density lipoprotein in obese adolescents","volume":"56","author":"Caccavello","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1210\/jc.2018-02772","article-title":"Isocaloric Fructose Restriction Reduces Serum d-Lactate Concentration in Children with Obesity and Metabolic Syndrome","volume":"104","author":"Bains","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"101920","DOI":"10.1016\/j.redox.2021.101920","article-title":"Protein glycation\u2014Biomarkers of metabolic dysfunction and early-stage decline in health in the era of precision medicine","volume":"42","author":"Rabbani","year":"2021","journal-title":"Redox Biol."},{"key":"ref_78","first-page":"277","article-title":"Dietary carbohydrates and fatty liver disease: De novo lipogenesis","volume":"21","author":"Chiu","year":"2018","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1146\/annurev.nu.16.070196.002515","article-title":"Regulation of hepatic de novo lipogenesis in humans","volume":"16","author":"Hellerstein","year":"1996","journal-title":"Annu. Rev. Nutr."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.2337\/diabetes.54.7.1907","article-title":"Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men","volume":"54","author":"Faeh","year":"2005","journal-title":"Diabetes"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s00059-022-05113-x","article-title":"New therapeutic approaches for the treatment of hypertriglyceridemia","volume":"47","author":"Schwarz","year":"2022","journal-title":"Herz"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Hieronimus, B., Griffen, S.C., Keim, N.L., Bremer, A.A., Berglund, L., Nakajima, K., Havel, P.J., and Stanhope, K.L. (2019). Effects of Fructose or Glucose on Circulating ApoCIII and Triglyceride and Cholesterol Content of Lipoprotein Subfractions in Humans. J. Clin. Med., 8.","DOI":"10.3390\/jcm8070913"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1053\/j.gastro.2017.05.043","article-title":"Effects of Dietary Fructose Restriction on Liver Fat, De Novo Lipogenesis, and Insulin Kinetics in Children With Obesity","volume":"153","author":"Schwarz","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-0033-1358523","article-title":"Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP","volume":"33","author":"Xu","year":"2013","journal-title":"Semin. Liver Dis."},{"key":"ref_85","first-page":"e220270","article-title":"Fructose drives de novo lipogenesis affecting metabolic health","volume":"257","author":"Gerber","year":"2023","journal-title":"J. Endocrinol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Song, Z., Xiaoli, A.M., and Yang, F. (2018). Regulation and metabolic significance of De Novo lipogenesis in adipose tissues. Nutrients, 10.","DOI":"10.3390\/nu10101383"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Steenson, S., Shojaee-Moradie, F., Whyte, M.B., Jackson, K.G., Lovegrove, J.A., Fielding, B.A., and Margot Umpleby, A. (2020). The effect of fructose feeding on intestinal triacylglycerol production and De Novo fatty acid synthesis in humans. Nutrients, 12.","DOI":"10.3390\/nu12061781"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2100456","DOI":"10.1002\/mnfr.202100456","article-title":"Dose Dependent Effects of Fructose and Glucose on de novo Palmitate and Glycerol Synthesis in an Enterocyte Cell Model","volume":"66","author":"Steenson","year":"2022","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/MOL.0000000000000653","article-title":"Dietary fructose and dyslipidemia: New mechanisms involving apolipoprotein CIII","volume":"31","author":"Hieronimus","year":"2020","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MOL.0b013e3283613bca","article-title":"Adverse metabolic effects of dietary fructose: Results from the recent epidemiological, clinical, and mechanistic studies","volume":"24","author":"Stanhope","year":"2013","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"154356","DOI":"10.1016\/j.metabol.2020.154356","article-title":"Synergistic effects of fructose and glucose on lipoprotein risk factors for cardiovascular disease in young adults","volume":"112","author":"Hieronimus","year":"2020","journal-title":"Metabolism"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ejcn.2011.159","article-title":"Consumption of fructose-sweetened beverages for 10 weeks reduces net fat oxidation and energy expenditure in overweight\/obese men and women","volume":"66","author":"Cox","year":"2012","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1194\/jlr.M089508","article-title":"Fructose-induced hypertriglyceridemia in rhesus macaques is attenuated with fish oil or ApoC3 RNA interference","volume":"60","author":"Butler","year":"2019","journal-title":"J. Lipid Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1172\/JCI37385","article-title":"Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight\/obese humans","volume":"119","author":"Stanhope","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1743-7075-9-68","article-title":"Consumption of fructose- but not glucose-sweetened beverages for 10 weeks increases circulating concentrations of uric acid, retinol binding protein-4, and gamma-glutamyl transferase activity in overweight\/obese humans","volume":"9","author":"Cox","year":"2012","journal-title":"Nutr. Metab."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1210\/jc.2014-3678","article-title":"Effect of a high-fructose weight-maintaining diet on lipogenesis and liver fat","volume":"100","author":"Schwarz","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.mehy.2016.05.026","article-title":"Fructose surges damage hepatic adenosyl-monophosphate-dependent kinase and lead to increased lipogenesis and hepatic insulin resistance","volume":"93","author":"Gugliucci","year":"2016","journal-title":"Med. Hypotheses"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1194\/jlr.RA119000423","article-title":"Role of angiopoietin-like protein 3 in sugar-induced dyslipidemia in rhesus macaques: Suppression by fish oil or RNAi","volume":"61","author":"Butler","year":"2020","journal-title":"J. Lipid Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.cca.2011.04.018","article-title":"Postprandial lipoprotein metabolism: VLDL vs chylomicrons","volume":"412","author":"Nakajima","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Harder, N.H.O., Hieronimus, B., Stanhope, K.L., Shibata, N.M., Lee, V., Nunez, M.V., Keim, N.L., Bremer, A., Havel, P.J., and Heffern, M.C. (2020). Effects of dietary glucose and fructose on copper, iron, and zinc metabolism parameters in humans. Nutrients, 12.","DOI":"10.3390\/nu12092581"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3945\/ajcn.110.002246","article-title":"Metabolic responses to prolonged consumption of glucose- and fructose-sweetened beverages are not associated with postprandial or 24-h glucose and insulin excursions","volume":"94","author":"Stanhope","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"E141","DOI":"10.1152\/ajpendo.00406.2017","article-title":"Plasma fatty acid ethanolamides are associated with postprandial triglycerides, ApoCIII, and ApoE in humans consuming a high-fructose corn syrup-sweetened beverage","volume":"315","author":"Price","year":"2018","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"E2034","DOI":"10.1210\/jc.2011-1050","article-title":"Circulating concentrations of monocyte chemoattractant protein-1, plasminogen activator inhibitor-1, and soluble leukocyte adhesion molecule-1 in overweight\/obese men and women consuming fructose- or glucose-sweetened beverages for 10 weeks","volume":"96","author":"Cox","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Gugliucci, A. (2023). The chylomicron saga: Time to focus on postprandial metabolism. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1322869"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1194\/jlr.D119000121","article-title":"Separation of postprandial lipoproteins: Improved purification of chylomicrons using an ApoB100 immunoaffinity method","volume":"61","author":"Jones","year":"2020","journal-title":"J. Lipid Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jpeds.2009.01.015","article-title":"Sugar-Sweetened Beverages, Serum Uric Acid, and Blood Pressure in Adolescents","volume":"154","author":"Nguyen","year":"2009","journal-title":"J. Pediatr."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Geidl-Flueck, B., Hochuli, M., Spinas, G.A., and Gerber, P.A. (2022). Do Sugar-Sweetened Beverages Increase Fasting FGF21 Irrespective of the Type of Added Sugar? A Secondary Exploratory Analysis of a Randomized Controlled Trial. Nutrients, 14.","DOI":"10.3390\/nu14194169"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"O\u2019Brien, P., and Corpe, C.P. (2016). Acute effects of sugars and artificial sweeteners on small intestinal sugar transport: A study using CaCo-2 cells as an in vitro model of the human enterocyte. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0167785"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00125-017-4475-0","article-title":"Sugar-sweetened beverage intake associations with fasting glucose and insulin concentrations are not modified by selected genetic variants in a ChREBP-FGF21 pathway: A meta-analysis","volume":"61","author":"McKeown","year":"2018","journal-title":"Diabetologia"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"E003288","DOI":"10.1161\/CIRCGEN.120.003288","article-title":"Sugar-Sweetened Beverage Consumption May Modify Associations Between Genetic Variants in the CHREBP (Carbohydrate Responsive Element Binding Protein) Locus and HDL-C (High-Density Lipoprotein Cholesterol) and Triglyceride Concentrations","volume":"14","author":"Haslam","year":"2021","journal-title":"Circ. Genom. Precis. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"E233","DOI":"10.1152\/ajpendo.00518.2025","article-title":"Testosterone deficiency synergistically exacerbates fructose-induced hepatic steatosis through gut microbiota and pyruvate in mice","volume":"330","author":"Takahashi","year":"2026","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/osp4.360","article-title":"Increased fructose consumption has sex-specific effects on fibroblast growth factor 21 levels in humans","volume":"5","author":"Rodgers","year":"2019","journal-title":"Obes. Sci. Pr."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3945\/ajcn.117.161539","article-title":"Fructose: Back to the future?","volume":"106","author":"Sievenpiper","year":"2017","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Noronha, J.C., Braunstein, C.R., Mejia, S.B., Khan, T.A., Kendall, C.W.C., Wolever, T.M.S., Leiter, L.A., and Sievenpiper, J.L. (2018). The effect of small doses of fructose and its epimers on glycemic control: A systematic review and meta-analysis of controlled feeding trials. Nutrients, 10.","DOI":"10.3390\/nu10111805"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/ajcn\/79.4.537","article-title":"Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity","volume":"79","author":"Bray","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Kanbay, M., Guler, B., Ertuglu, L.A., Dagel, T., Afsar, B., Incir, S., Baygul, A., Covic, A., Andres-Hernando, A., and S\u00e1nchez-Lozada, L.G. (2021). The speed of ingestion of a sugary beverage has an effect on the acute metabolic response to fructose. Nutrients, 13.","DOI":"10.3390\/nu13061916"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev-biochem-070820-125228","article-title":"Short- And Long-Term Adaptation to Altered Levels of Glucose: Fifty Years of Scientific Adventure","volume":"90","author":"Uyeda","year":"2021","journal-title":"Annu. Rev. Biochem."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/S0006-2952(02)01012-2","article-title":"Carbohydrate responsive element-binding protein (ChREBP): A key regulator of glucose metabolism and fat storage","volume":"63","author":"Uyeda","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cmet.2006.06.008","article-title":"Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis","volume":"4","author":"Uyeda","year":"2006","journal-title":"Cell Metab."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"E358","DOI":"10.1152\/ajpendo.00027.2006","article-title":"Deficiency of carbohydrate-activated transcription factor ChREBP prevents obesity and improves plasma glucose control in leptin-deficient (ob\/ob) mice","volume":"291","author":"Iizuka","year":"2006","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"15597","DOI":"10.1073\/pnas.0405238101","article-title":"Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription","volume":"101","author":"Ishii","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.bbrc.2010.10.113","article-title":"The role of O-linked GlcNAc modification on the glucose response of ChREBP","volume":"402","author":"Sakiyama","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"9116","DOI":"10.1073\/pnas.161284298","article-title":"A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver","volume":"98","author":"Yamashita","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.semcdb.2012.02.007","article-title":"Glucose sensing by ChREBP\/MondoA-Mlx transcription factors","volume":"23","author":"Havula","year":"2012","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ceb.2017.12.007","article-title":"Sugar sensing by ChREBP\/Mondo-Mlx\u2014new insight into downstream regulatory networks and integration of nutrient-derived signals","volume":"51","author":"Havula","year":"2018","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11745-015-4090-0","article-title":"Tissue Specific Effects of Dietary Carbohydrates and Obesity on ChREBP\u03b1 and ChREBP\u03b2 Expression","volume":"51","author":"Stamatikos","year":"2016","journal-title":"Lipids"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Iizuka, K., Takao, K., and Yabe, D. (2020). ChREBP-Mediated Regulation of Lipid Metabolism: Involvement of the Gut Microbiota, Liver, and Adipose Tissue. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.587189"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev.nutr.27.061406.093618","article-title":"ChREBP, a transcriptional regulator of glucose and lipid metabolism","volume":"27","author":"Postic","year":"2007","journal-title":"Annu. Rev. Nutr."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1038\/s42255-025-01399-3","article-title":"Glycerol-3-phosphate activates ChREBP, FGF21 transcription and lipogenesis in citrin deficiency","volume":"7","author":"Tiwari","year":"2025","journal-title":"Nat. Metab."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"10515","DOI":"10.1074\/jbc.M115.708982","article-title":"Metabolite regulation of nuclear localization of carbohydrate-response element-binding protein (ChREBP): Role of amp as an allosteric inhibitor","volume":"291","author":"Sato","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1042\/BCJ20200520","article-title":"The structure of importin \u03b1 and the nuclear localization peptide of ChREBP, and small compound inhibitors of ChREBP-importin a interactions","volume":"477","author":"Jung","year":"2020","journal-title":"Biochem. J."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1152\/physiol.00016.2015","article-title":"Integration of chrebp-mediated glucose sensing into whole body metabolism","volume":"30","author":"Baraille","year":"2015","journal-title":"Physiology"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1172\/JCI89934","article-title":"Lipogenic transcription factor ChREBP mediates fructose-induced metabolic adaptations to prevent hepatotoxicity","volume":"127","author":"Zhang","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Rabbani, N., and Thornalley, P.J. (2023). Hexokinase-linked glycolytic overload and unscheduled glycolysis in hyperglycemia-induced pathogenesis of insulin resistance, beta-cell glucotoxicity, and diabetic vascular complications. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1268308"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.molmet.2016.11.008","article-title":"A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism","volume":"6","author":"Fisher","year":"2017","journal-title":"Mol. Metab."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.2337\/db15-0239","article-title":"Induction of the ChREBP\u03b2 isoform is essential for glucose-stimulated \u03b2-cell proliferation","volume":"64","author":"Zhang","year":"2015","journal-title":"Diabetes"},{"key":"ref_137","first-page":"249","article-title":"ChREBP","volume":"64","author":"Iizuka","year":"2006","journal-title":"Nippon. Rinsho Jpn. J. Clin. Med."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.tem.2013.01.003","article-title":"Novel insights into ChREBP regulation and function","volume":"24","author":"Filhoulaud","year":"2013","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"C1234","DOI":"10.1152\/ajpcell.00875.2024","article-title":"ChREBP mediates metabolic remodeling in FBP1-deficient liver","volume":"328","author":"Wang","year":"2025","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"e96703","DOI":"10.1172\/jci.insight.96703","article-title":"Intestinal, but not hepatic, ChREBP is required for fructose tolerance","volume":"2","author":"Kim","year":"2017","journal-title":"JCI Insight"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.advenzreg.2006.01.010","article-title":"Roles for fructose-2,6-bisphosphate in the control of fuel metabolism: Beyond its allosteric effects on glycolytic and gluconeogenic enzymes","volume":"46","author":"Wu","year":"2006","journal-title":"Adv. Enzym. Regul."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Geidl-Flueck, B., and Gerber, P.A. (2017). Insights into the hexose liver metabolism\u2014Glucose versus fructose. Nutrients, 9.","DOI":"10.3390\/nu9091026"},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Iizuka, K. (2023). Recent Progress on Fructose Metabolism\u2014Chrebp, Fructolysis, and Polyol Pathway. Nutrients, 15.","DOI":"10.3390\/nu15071778"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"101196","DOI":"10.1016\/j.molmet.2021.101196","article-title":"Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction","volume":"48","author":"Gutierrez","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_145","first-page":"354","article-title":"Novel insights in intestinal and hepatic fructose metabolism: From mice to men","volume":"25","author":"Koene","year":"2022","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Rajas, F., Gautier-Stein, A., and Mithieux, G. (2019). Glucose-6 Phosphate, A Central Hub for Liver Carbohydrate Metabolism. Metabolites, 9.","DOI":"10.3390\/metabo9120282"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.tem.2022.07.007","article-title":"Fructose 1-phosphate, an evolutionary signaling molecule of abundancy","volume":"33","author":"Brouwers","year":"2022","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1172\/JCI81993","article-title":"ChREBP regulates fructose-induced glucose production independently of insulin signaling","volume":"126","author":"Kim","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1507\/endocrj.EJ12-0413","article-title":"Role of glucose-6-phosphate and xylulose-5-phosphate in the regulation of glucose-stimulated gene expression in the pancreatic \u03b2 cell line, INS-1E","volume":"60","author":"Iizuka","year":"2013","journal-title":"Endocr. J."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"101227","DOI":"10.1016\/j.molmet.2021.101227","article-title":"The Mediator complex kinase module is necessary for fructose regulation of liver glycogen levels through induction of glucose-6-phosphatase catalytic subunit (G6pc)","volume":"48","author":"Youn","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1128\/MCB.01576-12","article-title":"Glucose Induces Protein Targeting to Glycogen in Hepatocytes by Fructose 2,6-Bisphosphate-Mediated Recruitment of MondoA to the Promoter","volume":"33","author":"Petrie","year":"2013","journal-title":"Mol. Cell Biol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.febslet.2007.07.084","article-title":"Role of ChREBP in hepatic steatosis and insulin resistance","volume":"582","author":"Denechaud","year":"2008","journal-title":"FEBS Lett."},{"key":"ref_153","first-page":"376","article-title":"Postprandial metabolic effects of fructose and glucose in type 1 diabetes patients: A pilot randomized crossover clinical trial","volume":"63","author":"Souto","year":"2019","journal-title":"Arch. Endocrinol. Metab."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2337\/db19-0388","article-title":"Liver ChREBP protects against fructose-induced glycogenic hepatotoxicity by regulating L-type pyruvate kinase","volume":"69","author":"Shi","year":"2020","journal-title":"Diabetes"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature10986","article-title":"A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism","volume":"484","author":"Herman","year":"2012","journal-title":"Nature"},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Benhamed, F., Filhoulaud, G., Caron, S., Lefebvre, P., Staels, B., and Postic, C. (2014). O-GlcNAcylation Links ChREBP and FXR to Glucose-Sensing. Front. Endocrinol., 5.","DOI":"10.3389\/fendo.2014.00230"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2337\/db10-0452","article-title":"O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver","volume":"60","author":"Guinez","year":"2011","journal-title":"Diabetes"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.biochi.2010.12.017","article-title":"Damage-specific DNA binding protein 1 (DDB1) is involved in ubiquitin-mediated proteolysis of p27Kip1 in response to UV irradiation","volume":"93","author":"Iovine","year":"2011","journal-title":"Biochimie"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.biocel.2011.09.001","article-title":"Damage-specific DNA binding protein 1 (DDB1): A protein with a wide range of functions","volume":"43","author":"Iovine","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1042\/bst0210549","article-title":"Mechanism for the formation of methylglyoxal from triosephosphates","volume":"21","author":"Richard","year":"1993","journal-title":"Biochem. Soc. Trans."},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"de Bari, L., Scir\u00e8, A., Minnelli, C., Cianfruglia, L., Kalapos, M.P., and Armeni, T. (2020). Interplay among Oxidative Stress, Methylglyoxal Pathway and S-Glutathionylation. Antioxidants, 10.","DOI":"10.3390\/antiox10010019"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.2337\/db05-0857","article-title":"Methylglyoxal impairs the insulin signaling pathways independently of the formation of intracellular reactive oxygen species","volume":"55","author":"Pierron","year":"2006","journal-title":"Diabetes"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"101421","DOI":"10.1016\/j.redox.2019.101421","article-title":"Methylglyoxal interaction with superoxide dismutase 1","volume":"30","author":"Polykretis","year":"2020","journal-title":"Redox Biol."},{"key":"ref_164","first-page":"587","article-title":"Medical aspects of methylglyoxal metabolism","volume":"133","author":"Kalapos","year":"1992","journal-title":"Orv. Hetil."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12987-023-00477-6","article-title":"Methylglyoxal, a highly reactive dicarbonyl compound, as a threat for blood brain barrier integrity","volume":"20","author":"Berends","year":"2023","journal-title":"Fluids Barriers CNS"},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Alhujaily, M. (2024). Molecular Assessment of Methylglyoxal-Induced Toxicity and Therapeutic Approaches in Various Diseases: Exploring the Interplay with the Glyoxalase System. Life, 14.","DOI":"10.3390\/life14020263"},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Rabbani, N., and Thornalley, P.J. (2022). Emerging Glycation-Based Therapeutics\u2014Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23052453"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1113\/JP274438","article-title":"Maternal fructose consumption can affect offspring metabolic outcomes","volume":"595","author":"Gugliucci","year":"2017","journal-title":"J. Physiol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"e187376","DOI":"10.1172\/JCI187376","article-title":"Safety and efficacy of pharmacological inhibition of ketohexokinase in hereditary fructose intolerance","volume":"135","author":"Koene","year":"2025","journal-title":"J. Clin. Investig."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"13501","DOI":"10.1021\/acs.jmedchem.3c00715","article-title":"Discovery of a Novel Ketohexokinase Inhibitor with Improved Drug Distribution in Target Tissue for the Treatment of Fructose Metabolic Disease","volume":"66","author":"Zhu","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Elsaman, T., and Mohamed, M.A. (2025). Examining Prenylated Xanthones as Potential Inhibitors Against Ketohexokinase C Isoform for the Treatment of Fructose-Driven Metabolic Disorders: An Integrated Computational Approach. Pharmaceuticals, 18.","DOI":"10.3390\/ph18010126"},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Gugliucci, A. (2025). Exploring Glyoxalase Strategies for Managing Sugar-Induced Chronic Diseases. Life, 15.","DOI":"10.3390\/life15050794"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1021\/acs.jcim.5c02172","article-title":"Generative AI Uncovers Novel Chrebp\/Txnip Axis Inhibitors with Potential Anti-inflammatory Activity","volume":"66","author":"Qayyum","year":"2026","journal-title":"J. Chem. Inf. Model."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.biopha.2019.01.021","article-title":"Metformin enhances mitochondrial biogenesis and thermogenesis in brown adipocytes of mice","volume":"111","author":"Karise","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1042\/BJ20150125","article-title":"Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity","volume":"468","author":"Ford","year":"2015","journal-title":"Biochem. J."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"E208","DOI":"10.1161\/ATVBAHA.120.315708","article-title":"New Insight Into Metformin-Induced Cholesterol-Lowering Effect Crosstalk Between Glucose and Cholesterol Homeostasis via ChREBP (Carbohydrate-Responsive Element-Binding Protein)-Mediated PCSK9 (Proprotein Convertase Subtilisin\/Kexin Type 9) Regulation","volume":"41","author":"Hu","year":"2021","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1210\/ME.2015-1090","article-title":"New insight into metformin action: Regulation of chREBP and FOXO1 activities in endothelial cells","volume":"29","author":"Li","year":"2015","journal-title":"Mol. Endocrinol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41597-023-02596-z","article-title":"A high throughput screen for pharmacological inhibitors of the carbohydrate response element","volume":"10","author":"You","year":"2023","journal-title":"Sci. Data"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1038\/s41467-024-45548-w","article-title":"The transcription factor ChREBP Orchestrates liver carcinogenesis by coordinating the PI3K\/AKT signaling and cancer metabolism","volume":"15","author":"Benichou","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1038\/s41467-025-57241-7","article-title":"Molecular glues of the regulatory ChREBP\/14-3-3 complex protect beta cells from glucolipotoxicity","volume":"16","author":"Katz","year":"2025","journal-title":"Nat. Commun."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/16\/8\/1313\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:34:28Z","timestamp":1786437268000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/16\/8\/1313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":181,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["life16081313"],"URL":"https:\/\/doi.org\/10.3390\/life16081313","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]}}}